ASSOCIATION OF HISTOLOGIC MEASUREMENT WITH ENDOSCOPIC OUTCOMES AFTER ONE YEAR OF TREATMENT WITH MIRIKIZUMAB IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE

Fernando Magro  1     Gert De Hertogh  2     Marijana Protic  3     Lai Shan Chan  3     Paul Pollack  3     Brian G. Feagan  4     Noam Harpaz  5     Rish Pai  6     Walter Reinisch  7    
1 University Hospital São João, Porto, Portugal
2 University Hospital Leuven, Leuven, Belgium
3 Eli Lilly and Company, Indianapolis, United States
4 Robarts Clinical Trials Inc., London, Canada
5 Icahn School of Medicine at Mount Sinai, New York City, United States
6 Mayo Clinic, Scottdale, United States
7 Medical University of Vienna, Wien, Austria

Session
IBD (Posters)

Conference
UEG Week Vienna 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing